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ABSTRACT 
 
Introduction 
 
Delays in diagnosing and treating tuberculosis increase the risk of transmission, morbidity 
and mortality especially in low socio-economic settings with high HIV and TB rates. The 
aim of this study was to determine factors associated with the delay in the diagnosis and 
treatment of suspected TB by HIV status in hospitalised patients in South Africa. 
 
Methods 
 
This study was a secondary analysis of data from a three centre prospective cohort of 
inpatients recruited between 2006 and 2009 that were clinically diagnosed with active TB 
on admission. 
 
Results 
 
Data from 1018 patients (67% female) of a median age of 36 years (IQR: 30-44) with 
known HIV status were analysed: 875 (86%) positive and 143 (14%) negative. HIV positive 
patients had significantly longer median total delays relative to the negative (39 days, 
IQR: 28-74 vs. 32 days, IQR: 21-56; p<0.02). Unemployment, seeking prior treatment and 
use of cotrimoxazole predicted total delay in the HIV positive patients. 
 
Conclusion 
 
Patient delay is high in HIV positive patients compared to the HIV negative. Public health 
interventions targeting earlier diagnosis of TB disease in HIV positive patients should be 
enhanced. 
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CHAPTER ONE: INTRODUCTION 
 
The chapter gives an overview of the burden of tuberculosis (TB) and its significance in 
public health. It also discusses the double burden of TB and HIV in sub-Saharan Africa and 
South Africa in particular. This chapter further reviews the literature on determinants of 
delay in diagnosis and treatment of TB. The problem statement, justification for 
conducting the study and research objectives are also included. 
 
1.1 Background 
 
Tuberculosis (TB) is one of the most common infectious diseases that cause morbidity and 
mortality worldwide (1). The World Health Organisation (WHO) ranks TB alongside HIV as 
a leading cause of death among infectious diseases globally (2). In 2015, approximately 
10.4 million people worldwide were infected with TB (5.9 million men, 3.5 million women 
and 1.0 million children) and 11 percent of all new TB cases were HIV positive (2). 
Although there has been a 42 percent decrease in the prevalence of TB globally from 
1990 to 2015, the number of cases (174 cases per 100,000 populations as of the year 
2014) is still unacceptably high (2). Furthermore, there has not been any significant 
decrease in prevalence in developing countries especially in sub-Saharan Africa where the 
double burden of TB and HIV is high (1). The WHO Global Tuberculosis Report of the year 
2016 estimated that the number of deaths due to TB was 1.4 million in 2015 and an 
additional 0.4 million deaths occurred among TB and HIV co-infected patients (2). Over 95 
percent of these deaths took place in low and middle-income countries. These 
unacceptably high TB mortality rates can be controlled with a timely diagnosis and correct 
treatment (1). 
 
In sub-Saharan Africa, South Africa has the highest burden of HIV and TB. A South African 
household survey approximated that 18.8 percent of the reproductive age population (15 
to 49 years) are HIV positive (3). The incidence of TB in South Africa is among the highest 
in the world at 834 new cases per 100,000 people (2). The profile of HIV epidemic in 
South Africa is also among the highest in the world. In the year 2012, there was an 
estimated 469,000 new HIV infections, and about 6.4 million people were living with 
HIV(3). Furthermore, South Africa's HIV and TB co-infection rates are highest in the world 
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with an estimated incidence of 473 new cases per 100,000 people (2). Such elevated 
levels of TB and HIV co-infection substantiates the fact that HIV/AIDS drives the TB 
epidemic in South Africa and it also explains why TB is the leading cause of death among 
people infected with HIV in the country (4). 
 
In South Africa, the population group that is highly affected by TB and which constitutes 
88 percent of all TB cases are people aged 30 to 39 years, living in townships and informal 
settlements (5). It may, therefore, imply that TB is a disease that affects people in poverty 
stricken environments as most of the township and informal settlement settings are 
characterised by overcrowding and low socio-economic status, all of which provide a 
favourable environment for TB infection and disease (5). 
 
Gauteng is one of the nine provinces in South Africa and home to South Western 
Townships (SOWETO). Soweto is one of the largest and most populated townships 
characterised by several informal settlements. The prevalence of HIV in Gauteng province 
is 12.4 percent (3). Program data from the South African Department of Health estimates 
that the province has the third-highest number of people with TB in the country with an 
estimated TB incidence of 376 per 100,000 people and around 30 to 40 percent of TB 
patients are infected with HIV (Department of Health, unpublished data ). It has been 
established that reactivation of latent TB infection plays a significant role in the escalating 
TB epidemic in South Africa, as even populations with extremely effective Directly 
Observed Therapy (DOT) programs such as miners experience unprecedented increases in 
TB morbidity (6). 
 
1.2 Aetiology of tuberculosis 
 
The bacillus, Mycobacterium tuberculosis (Mtb), causes TB and the source of Mtb 
infection is commonly individuals with untreated pulmonary TB. Transmission to 
susceptible persons occurs when they have been exposed to droplet nuclei containing 
viable organisms that have been aerosolized from an infectious source (1). Most of the 
individuals infected with Mtb do not show symptoms. However, in a minority of infected 
people, the initial infection may progress to active clinical disease within two years (7). 
Although reactivation of tuberculosis occurs years after the initial infection in a small 
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proportion of patients, the majority of persons infected with Mtb never develop clinical 
disease (8). 
 
Early detection of TB disease is critical in alleviating transmission and prolonging of the 
disease in an individual. Furthermore, it cuts down on time between onset of first 
symptoms, diagnosis and treatment (9). Contagiousness of TB increases as an infected 
person delays seeking treatment (10) thus exposing those sharing the same surrounding 
with the patient to TB. 
 
Many authors have documented that failure of TB control mechanisms are a contributing 
factor to the delay in diagnosis and treatment of TB (9, 10). A longitudinal cohort study 
conducted in Guinea-Bissau showed that delayed diagnosis and treatment results in 
escalating the severity of the disease, mortality and transmission (9). There is an 
increased risk of TB transmission if the time between the onset of first symptoms of the 
disease, diagnosis and treatment is long (9). A cross-sectional study conducted in Ethiopia 
demonstrated that delayed treatment results in the likelihood of bacterial resistance 
which leads to an increased mortality risk and consequently the success of the treatment 
decrease (11). A study conducted in Iran further documented that bacterial resistance 
which resulted in the occurrence of multidrug-resistant tuberculosis (MDR-TB) made TB 
control to be more challenging and this vicious cycle continues (12). 
 
Studies conducted in most developing countries have shown that delays in diagnosis and 
treatment of TB occur in both high and low TB prevalence settings like sub-Saharan 
African countries and Croatia respectively (13-17). Different authors have widely 
recommended that understanding the factors that lead to the delay in diagnosis and 
treatment is one of the key steps to be considered when designing and implementing a 
TB control programme (18, 19). 
 
1.3 Problem statement 
 
Globally, most authors have attributed delays in TB diagnosis and treatment to the female 
gender, HIV infection, old age, alcoholism, low social-economic status, lack of knowledge 
about TB symptoms among both patients and health workers and prior unspecific 
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treatment for TB (10, 13, 20-22). Studies conducted in Sub-Saharan Africa where poverty 
and the burden of HIV are high have found similar results. However, the Sub-Saharan 
studies have further found that unemployment, seeking prior treatment, perceived 
stigma and crowding index determine delays in TB diagnosis and treatment (14, 17, 23, 
24). In developed countries with a low burden of TB, low index of TB suspicion by patients 
and health care workers continue to influence the delays in TB diagnosis and treatment 
(1). In Sub-Saharan African countries, persistent poverty and underdevelopment which 
affects access to proper TB diagnostic and treatment services remain a key factor which 
influences the delays (18, 25). 
 
Delay in the diagnosis and treatment of TB is often classified into patient, health system 
and total (sum of patient and health) delays and the determinants of all these classes of 
delay have been widely assessed (13, 19, 21, 24). Although such determinants have been 
widely reported, there is limited literature comparing them by HIV status in hospitalised 
patients in South Africa where the burden of TB and HIV is high. 
 
1.4 Justification for study 
 
There is a need for evidence-based interventions that would result in effective TB 
diagnostic and treatment for both HIV positive and negative patients to reduce diagnostic 
delay and expedite TB treatment. However, there is limited evidence which demonstrates 
whether determinants of delay in TB diagnosis and treatment in HIV-infected cases are 
different from those who are HIV negative. In South Africa, TB and HIV co-infection rates 
are high compared to other countries in sub-Saharan Africa (5).Understanding the 
determinants of delay by HIV status in such a setting is critical to effective TB 
programming. This study, therefore, addressed these knowledge gaps and the results will 
inform the policies, strategies and targeted interventions that could improve early 
detection and treatment of TB among HIV positive and HIV negative patients. Such 
interventions would ultimately reduce TB-related morbidity and mortality. 
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1.5 Literature review 
 
1.5.1 Definition of delay 
 
Several authors have classified delay into patient, health care system and total delay (10, 
14, 24). A recent study conducted in Ghana defined patient delay as the duration of time 
between the onset of the first TB symptoms and first contact with public health services 
(23). Studies conducted in South Africa and Italy used similar definition (20, 24). Many 
authors agree that health system delay is the number of days between making contact 
with a health facility and initiation of anti-tuberculosis treatment and that the sum of 
patient and health system delay is the total delay (8, 10, 24, 26). 
 
Many quantitative studies conducted across the world have measured delay as a binary 
outcome where a particular cut-off point is set to describe prolonged delay (18, 24). The 
definition of prolonged delay varies from one study to another depending on the study 
setting. The period of approximately a month or more from initial symptoms to seeking 
any medical care has been used to characterise prolonged patient delay, while a period of 
15 days from visiting a medical facility to initiation of treatment has been used to 
describe prolonged health system delay (9, 13, 18, 24). A study conducted in South Africa 
defined prolonged patient delay as having symptoms for at least 28 days before seeking 
any medical care while prolonged health system delay was defined as starting anti-
tuberculosis treatment at least seven days after first reporting to any medical facility 
(24).Other authors have used the median value of the observed data as a cut-off for 
prolonged delay (27). No standard period defines total delay from the onset of symptoms 
to the commencement of TB treatment. However, some authors have suggested that this 
period should not be more than one month (28) while others have argued that the period 
can be as long as two months (29). 
 
1.5.2 Distribution of delay 
 
Research from Zimbabwe, a developing country with a high burden of HIV and TB, found 
that the median patient delay was 28 days (17). Similar results emerged from a 
retrospective cohort study conducted in Norway, a developed country with low burden 
6 
 
HIV and TB (30). However, different distribution of patient delay, median 59 days, has 
been observed in a recent study conducted in Ghana comprising of suspected TB patients 
who were 15 years and older and were admitted between 1st June 2013 and 31st May 
2014 in Hohoe Municipality (23). Considerable differences also emerged from a study 
consisting of 104 patients admitted in South Africa, a setting with high HIV and TB burden, 
in 2008 where the median patient delay was 14 days (31). It may, however, be difficult to 
ascertain whether the differences in the distribution of patient delay from different study 
settings was due to bias or due to actual observed differences across the study settings. 
This is because cross-sectional and retrospective cohort studies are more prone to recall 
bias where the patients may not correctly remember the date during which the first 
symptoms suggestive of TB infection occurred. 
 
The distribution of health system delay varies extensively in different settings. For 
instance, a study conducted in seven Croatian counties between April and December 
2006 among adults of 15 years of age and above found that the median health system 
delay was 15 days (16). On the contrary, a recent study conducted in Zimbabwe found 
that the median health system delay was 2 days (IQR: 1-5) (17). A cross-sectional study 
conducted in 10 sub-districts of Bangladesh whose aim was to examine the gender 
variations in patient and health system delay among TB patients found the median health 
system delay to be one day for both males and females (32). Different results were 
obtained from two cross-sectional studies conducted in urban settings of high HIV and TB 
burden countries Malawi and Mozambique were the median health system delay was 59 
days (IQR: 26–108) and 62 days (IQR: 37–120) respectively(25, 33). Researchers have 
associated health system delay to the index of TB suspicion among health workers (10, 
18, 33). Differences in levels of knowledge about signs and symptoms of TB could, 
therefore, be the reason why there is a high variation in the distribution of health system 
delay across different studies. 
 
Previous studies have shown vast differences in the total delay across several settings 
which range from 25 days to 185 days and the main reason for such differences has been 
attributed to variability in demographic factors among others (8, 9, 11, 12). A prospective 
cohort study conducted in Amhara Region of Ethiopia from October 2013 to May 2015 
among newly diagnosed PTB patients who were 15 years of age and above found that the 
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median total delay was 60 days(34). A study that was meant to describe the risk factors 
for treatment delay and the effect of delay on the severity of tuberculosis (TB) in a 
prospectively followed TB cohort at the Bandim health project in Guinea-Bissau found 
that the median total delay was 85 days (9). A systematic review whose aim was to 
systematically review Indian literature on delays in TB diagnosis and treatment obtained a 
median total delay of 55 days (IQR: 47–62) (19). 
 
1.5.3 Determinants of delay 
 
Researchers from different countries have demonstrated that delays in treatment and 
diagnosis of TB are affected by a wide range of demographic and diagnostic factors 
among others (8-12, 18). According to these studies, these predictors of delay have 
appeared to differ sometimes based on the research setting. A systematic review 
conducted elsewhere indicated that the most common factors include, old age, low level 
of education, little public awareness of TB, long distance to health facilities, male gender, 
the first visit by a physician not familiar with the National TB control programme, rural 
residence and HIV infection(10). Furthermore, researchers have studied other 
characteristics that affect delay in diagnosis and treatment of TB including socio-
economic status, crowding index, Body Mass Index (BMI), use of medication that suppress 
TB infection e.g. cotrimoxazole, use of alcohol and cigarettes and employment status(18, 
23, 24, 33). These characteristics have shown to have an association with a delay in other 
settings, and they have shown no relationship in others. 
 
1.5.3.1 Prolonged patient delay 
 
Studies conducted in developed countries have indicated that the elderly (> 65 years) are 
more likely to experience prolonged patient delay than the younger patients while sex, 
smoking and alcohol use are not associated with prolonged patient delay (30, 35). Some 
studies conducted in developing countries agree with the notion that old age is related to 
prolonged patient delay and that sex is not associated with delay (14, 23). Conflicting 
revelations concerning gender were found in a study conducted among a high HIV 
population in South Africa where male sex was independently associated with longer 
patient delay (31). A systematic review that was done in sub-Saharan African countries 
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with a high burden of TB and HIV further demonstrated that patients who sought 
treatment elsewhere before TB treatment had a longer patient delay than those who 
never seek treatment elsewhere (14). A study conducted in Ghana demonstrated that 
patients who are employed have higher odds of prolonged patient delay (OR: 2.87; 95 % 
CI: 1.02–8.09; P<0.046) when compared to the unemployed ones (23). Several studies 
conducted in both developed and developing countries have discovered that body mass 
index, HIV infection and socio-economic status do not significantly predict prolonged 
patient delay (8, 13). A study conducted in Thailand found that being HIV positive was 
associated with reduced odds of prolonged patient delay(36) while Storla et al in a 
systematic review found the direct opposite where HIV infection was associated with 
increased odds of prolonged patient delay (10). The Thailand study was conducted in a 
high TB and HIV epidemic region which could mean that there was increased level of 
awareness about HIV and TB co-infection hence the patients had to seek medical care in 
time. On the other hand, the systematic review might have included some studies that 
were conducted in low HIV and TB-endemic region, and people's suspicion of TB was low 
since it was not a common condition within their settings and awareness was low. Storla’s 
results can, however, be explained based on revelations in urban India where fear of 
stigma and discrimination associated with HIV infection led to patients delay in seeking 
medical care (37). 
 
1.5.3.2 Prolonged health system delay 
 
Although some studies have not found any association between HIV status and prolonged 
health system delay (10, 31), studies conducted in Northwest Ethiopia and Thailand 
revealed that HIV-positive patients were less likely to have increased health systems delay 
compared to HIV-negative patients (8, 36). According to the study conducted in Thailand, 
patients with HIV infection present more severe symptoms suggestive of TB disease than 
those with HIV negative making it easier and quicker for health care workers to suspect 
TB and initiate them on treatment than those that are negative (36). The Northwest 
Ethiopian study gave a different explanation by indicating that health care workers have a 
high index of TB suspicion among HIV positive patients than HIV negative ones which 
accelerates diagnosis of TB among self-reported patients unlike those without HIV in 
areas were high TB and HIV co-infection exist (8). Furthermore, in such settings there 
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could have been increased awareness of TB among health care workers resulting in 
reduced period to diagnose and initiate TB treatment among patients. 
 
Previous research has also revealed that patients who had sought treatment elsewhere 
had higher odds of non-parametric health system delay than those who never sought 
treatment elsewhere (13, 25, 31). In additional to being in agreement with such findings, 
a study conducted in Khuzestan province in Iran demonstrated that smoking results in 
increased odds of prolonged health system delay (13). However, several findings from 
studies carried out in different settings have shown that smoking is not associated with 
prolonged health system delay (14, 30, 33). There is no clarity in the way the frequency or 
extent of smoking was defined in the Khuzestan province study, and this could be the 
source of variation with other studies that found conflicting results since most considered 
those who have ever smoked regardless of whether they stopped or not. 
 
In other studies, researchers have established an association between employment status 
and prolonged health system delay in which employed patients experienced shorter 
health delay than the unemployed (31). 
 
1.5.3.3 Prolonged total delay 
 
Research has demonstrated that the main problem in delay appears to be a vicious cycle 
of frequent visits at the same healthcare level, resulting in nonspecific antibiotic 
treatment and failure to access specialised TB services (9, 13, 38). Studies have associated 
the level of socioeconomic status to health seeking behaviour of individuals. For instance, 
studies conducted in Tanzania, Brazil and Hong Kong showed that people who were of 
low socioeconomic status were more likely to experience delays in diagnosis and 
treatment of TB (39-41). A related discovery was made in studies conducted in Rwanda 
and Gambia which showed that prolonged total delays were prevalent in rural residence 
which other authors have also associated with low socioeconomic status (42, 43). Much 
as other studies have found no association between gender, smoking and alcohol intake 
and delays in diagnosis and treatment of TB (39, 44), but studies conducted elsewhere 
have shown that female sex, alcohol consumption and smoking are associated with 
prolonged total delay(13, 24). 
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In most study settings, health system delay has been a major contributor to prolonged 
total delay than patient delay. A comparison of patient delay and health system delay in 
South Africa’s rural Northern Province found the health system delay to be a much larger 
problem than patient delay (45). Several studies agree with this notion and further 
demonstrated that low index of suspicion for diagnosing TB among health care providers 
is the leading cause of the problem (13, 15, 21). Amongst the factors discussed in this 
review, some researchers have isolated lack of public awareness of signs and symptoms 
of TB among health workers and the general population as the most important factor 
(21). Research conducted in Ethiopia also showed that limited knowledge about the signs 
and symptoms of TB caused a delay in referring patients to facilities, as well as a delay in 
diagnosing TB at the health facility (15). A comparative study of knowledge about 
tuberculosis in two cities with different tuberculosis epidemiological index in Khuzestan 
revealed that awareness about the disease in the general population and some health 
professionals is low (13). 
 
1.6 Research qquestion 
 
What are the determinants of delay in the diagnosis and treatment of suspected TB 
among HIV positive patients compared to HIV negative patients in three hospitals (Chris 
Hani Baragwanath, Selby Park and Tshepong hospital) in South Africa between 2006 and 
2009? 
 
1.7 Aim of study 
 
To compare the determinants of delay in diagnosis and treatment of suspected TB among 
HIV positive and HIV negative patients in three hospitals (Chris Hani Baragwanath, Selby 
Park and Tshepong hospital) in South Africa between 2006 and 2009 
 
1.8 Objectives of study 
1. To identify demographic and clinical differences between HIV positive and negative 
TB patients. 
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2. To determine the distribution of patient, health care system and total delay in days 
stratified by HIV status. 
3. To determine factors associated with prolonged patient, health care system and 
total delays in diagnosis and treatment of suspected TB by HIV status. 
 
1.9 Report structure  
 
This report has five chapters; the introduction, methods, results, discussion and 
conclusion. The introduction gives an overview of the dual burden of HIV and tuberculosis 
(TB) and its significance in public health. It also reviews the literature on determinants of 
delay in diagnosis and treatment of TB and provides the rationale as well as objectives for 
the research. The methods chapter describes the study design, study population, data 
management, variables, statistical methods and data analysis as well as ethical 
considerations for the study. The results chapter provides details of the research findings 
after analysing data. The discussion chapter reviews the findings of the study in relation 
to available literature and provides possible deduce explanations to observed results. The 
conclusion provides recommendations to public health practice and policy based on the 
results. It also discusses the strength and limitations of the study.    
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CHAPTER TWO: METHODS 
 
This chapter presents a description of the study design, study population, data 
management, variables, statistical methods and data analysis as well as ethical 
considerations for the study. 
 
2.1 Study design 
 
This was a retrospective cohort study which utilised secondary data from a three- centre 
prospective cohort of inpatients who were clinically diagnosed during the first 24 hours of 
admission with active TB in three hospitals (Chris Hani Baragwanath Academic Hospital 
and Selby Park Hospital, both in Gauteng Province, and Tshepong Hospital in North West 
Province) in South Africa between August, 2006 and October, 2009. The primary study 
aimed at determining factors associated with mortality in hospitalised TB patients with 
active TB irrespective of their HIV status. Data for the primary study was corrected using 
hospital records and predesigned questionnaires which were administered to the 
patients.  
 
2.2 Study population and sampling 
 
The study based on data from a three-centre prospective cohort of inpatients clinically 
diagnosed with active TB in South Africa between 2006 and 2009. The participants in the 
parent study were adults who were at least 18 years of age and TB had to be included in 
the differential diagnosis during the first 24 hours of admission. Both HIV positive and 
negative patients formed part of the study population, and the total number of 
participants recruited was 1018 people. The analysis included all enrolled participants 
with known HIV status. 
 
2.3 Data management 
 
The data for the secondary analysis was obtained from the Datafax system at the 
Perinatal HIV Research Unit (PHRU) of Chris Han Baragwanath hospital. The data were 
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imported into STATA version 13.1 (Stata Corporation, College Station, Texas, USA) for 
statistical analysis. The database was monitored and cleaned on an ongoing basis with 
quality assurance processes in place. Before analysing, validity checks were done to 
ensure completeness and to identify transposition, copying, consistency and range errors. 
This was done by performing frequencies and cross tabulations. Discrepancies were 
resolved by comparing the database with the hard copy of the forms. The database was 
then corrected accordingly. The variables of interest were recoded and categorised as 
necessary. 
 
2.4 Measurement of variables 
 
All variables were defined before the data were analysed. 
 
2.4.1 Exposure 
 
HIV status: The variable was measured as a binary variable and was defined as either HIV 
positive or HIV negative. The information was obtained from the medical history, and it 
was confirmed by results of the laboratory examination of the patient's blood where 
either two rapid HIV test or Enzyme-Linked Immunosorbent Assay (ELISA) test was 
conducted. Conclusive evidence of one’s HIV status was ascertained from the laboratory 
examination results. Missing information from the laboratory results was replaced by 
information from the medical history. 
 
2.4.2 Potential confounders and covariates 
 
 Age: This was calculated from the date of birth to the date of admission. Age was 
self-reported and verified through an identity document. Age was categorised 
because it was not normally distributed for both HIV positive and HIV negative 
patients. The age groups that were used were chosen based on the age limit on 
inclusion criteria and also in line with what is used by most authors: 
18 – 29 years 
30 – 44 years 
>45 years 
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 Sex: This binary variable was self-reported and was categorised as follows: 
Male 
Female 
 
 Socio-economic status (SES): Factor analysis using a list of variables describing a 
variety of assets and other possessions of the participant were used to create 
three categories of the SES variable as follows: 
Lower class 
Middle 
Upper middle class 
These groups were chosen because the area where the most participants come 
from (i.e. SOWETO) is of low socioeconomic profile and most people in the area 
are either in the poor or middle class. 
 
 Type of house: This variable was binary, and was recoded from a five-category 
variable which included brick house, shack, hostel, garage and other. The recoded 
variable was categorised as ‘brick house' and ‘other' where all groups apart from 
brick house formed part of the ‘other' category. 
 
 Numbers of rooms in the house: This was measured as a discrete variable, and for 
each patient, it was defined as the number of rooms in the house where people 
sleep. 
 
 Number of people in the house: This was measured as a discrete variable, and for 
each patient, it was defined as the number of people living in the household. 
 
 Crowding Index: This variable was generated by dividing the number of people in 
a household divided by the rooms in the house and was measured as a continuous 
variable. 
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 Employment status: This binary categorical variable was classified as either 
‘employed' of ‘unemployed'. Those who were in the unemployed category had to 
be unemployed for more than three days a week for the past two months. 
 
 Smoking: This was self-reported, and it was a binary variable with a ‘yes' or ‘no' 
response. The variable was defined as current smokers or those who had ever 
smoked. 
 
 Alcohol consumption: This was self-reported, and it was a binary variable with a 
‘yes' or ‘no' response. The variable was defined as those who currently drink 
alcohol or those who had ever drunk alcohol against those who had never 
consumed alcohol. 
 
 Admission time: This variable was generated from the day of admission variable. 
The day of admission was changed to a format which indicated the day of the 
week during which the patient was admitted. It was then categorised as 
‘weekday', for Monday to Friday, and ‘weekend' for Saturday and Sunday. 
 
 Body Mass Index (kg/m2): BMI was calculated by dividing weight (in kg) by the 
square of height (in meters). It was then recorded and categorised as underweight 
for BMI<18 kg/m2, normal weight for BMI 18.5-24.9 kg/m2 and overweight or 
obese for BMI >25 kg/m2. The classification of the BMI variable was based on 
standard WHO guidelines for BMI classification. 
 
 Cotrimoxazole: This was self-reported, and it was a binary variable with a ‘yes' or 
‘no' response. The variable was defined as those who are currently taking 
Cotrimoxazole or have taken the drugs in the past week for longer than five days. 
 
 Sought treatment elsewhere: This was self-reported, and it was a binary variable 
with a ‘yes' or ‘no' response. The variable was defined as having been admitted to 
another doctor, clinic or hospital because of the patient's current problem before 
their current admission. 
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 Hospitals type: This categorical variable was based on which Hospital the patients 
were admitted, and it had three groups including: 
Chris Hani Baragwanath hospital in Soweto 
Selby hospital in Johannesburg Central Business District 
Tshepong hospital in Klerksdorp 
 
2.4.3 Outcome variables 
 
The outcome variable was delay and it was measured on three levels of patient delay, 
health system delay and total delay. 
 
 Patient delay: This discrete variable was defined as the number of days between 
onset of TB symptoms and the first contact with any health care provider. The 
longest duration of symptoms suggestive of TB was considered. 
 
 Prolonged patient delay. This variable was measured as a binary outcome. Study 
subjects with a patient delay of more than 28 days were categorised as having 
experienced prolonged patient delay unlike those that had a patient delay of 
fewer than 28 days. 
 
 Health system delay: It was defined as the number of days between admission 
and initiation of anti-tuberculosis treatment. The variable was obtained from the 
difference between the first day of admission to a health facility and the first day 
the patient was initiated on anti-tuberculosis treatment. 
 
 Prolonged health system delay: This binary outcome variable was derived from 
the discrete health system delay variable. Patients who experienced 7 days or 
more in health system delay were classified into the prolonged health system 
delay category while those who had less than 7 days were not. 
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 Total delay: The variable was obtained from the sum of patient and health system 
delay. 
 
 Prolonged total delay: Similarly, the prolonged total delay variable was measured 
as a binary outcome. Patients with 35 days or more of total delay were grouped 
into the prolonged total delay category while those with less than 35 days total 
delay were not. 
 
2.5 Statistical methods and data analysis 
 
2.5.1 Exploratory and descriptive analysis 
 
Exploratory and descriptive data analysis of frequency and percentages were done for 
categorical variables. A test of normality was conducted for continuous variables, and 
since it was found that the data was not normally distributed, the median and 
interquartile ranges were done for the continuous variables stratified by HIV status. For 
categorical variables, Pearson's Chi-squared tests were conducted to assess whether the 
different proportions of the various categorical variables were the same in the population 
with HIV positive patients compared to that with HIV negative patients. For continuous 
variables, Mann Whitney U test (Wilcoxon Rank Sum test) was done to assess whether 
the population median for HIV positive patients was different compared to that with HIV 
negative patients. 
 
2.5.2 Calculation of Patient, Health system and Total delay 
 
The overall frequency of all types of delay for HIV positive and HIV negative patients was 
calculated for some socio-demographic and clinical variables to determine the median 
distribution and IQR for patient, health care system and total delay. Continuous variables 
were assessed for normality and since they were not normally distributed non-parametric 
tests were used. Mann Whitney U test (Wilcoxon Rank Sum test) test was done to 
determine whether the median delay in the population with HIV positive patients was 
different compared to that with HIV negative patients. 
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2.5.3 Assessment of confounding and effect modification 
 
Covariates were investigated for confounding and effect modification for each type of 
prolonged delay. Figure 1 shows the confounding/effect modification pathway that was 
investigated: 
  
Figure 1: Diagram of confounding pathway 
 
(Exposure)        (Outcome) 
 
 
 
(Confounder/Effect modifier) 
 
 
 
 
The assessment was done using Mantel Haenszel test of homogeneity of odds ratios and 
HIV status as the exposure. The crude odds ratios were calculated for prolonged delay 
and sought prior treatment. HIV stratum-specific odds ratios were then calculated for the 
same relationship. Effect modification was ascertained when the stratum specific odds 
ratios provided were different. For similar stratum specific estimates, pooled odds ratios 
were calculated. Confounding was confirmed when crude odds ratio were different from 
adjusted odds ratios. The algorithm for assessment of confounding and effect 
modification is outlined in Figure 2.    
 
 
 
 
 
 
HIV status 
 Covariates: age, sex, sought 
treatment elsewhere 
Prolonged delay (Patient, 
Health system and Total) 
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Figure 2: Flow chart of algorithm for confounding/effect modification assessment 
 
 
 
2.5.4 Inferential analysis for prolonged Patient, Health system and Total delay 
 
Logistic regression analysis was used to estimate the odds ratios (ORs) for all types of 
prolonged delay. Prior to fitting the regression models, several assumptions were checked 
that necessitates the use of the binomial logistic regression including the assumption of 
multicollinearity among independent variables and the linear relationship between 
continuous independent variables and the log odds. 
 
Univariate logistic regression models were fitted for each type of prolonged delay to 
determine odds ratios, 95% confidence intervals (CIs) and associated P-values for 
different covariates. Significant variables with P < 0.05 were fitted into a multivariate 
model to determine predictors of all prolonged delays stratified by HIV status. Likelihood 
ratio tests were conducted to assess whether adding particular variables to the 
multivariate model helped to improve the model and those which improved the model 
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were retained as opposed to those which did not contribute to improving the model. This 
was followed by the Hosmer-Lemeshow goodness of fit test which was conducted to 
check model fit. 
 
2.6 Ethical approval 
 
Ethics approval for this study was obtained from the University of the Witwatersrand, 
Human Research Ethics Committee (Wits HREC) (clearance certificate number M160548). 
Approval for the initial study was obtained from the Wits HREC (clearance certificate 
number M051116). Study participants gave informed consent to participate in the 
primary study.  
 
During this analysis, the information was kept anonymous. A data sharing agreement was 
also made between the principal investigator and the owners of the data, in this case, 
PHRU. 
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CHAPTER THREE: RESULTS 
 
This chapter provides a detailed explanation of the study findings. 
 
3.1 Overview 
 
A total of 1025 suspected TB cases were identified from the primary study. Among the 
identified cases, 481(47%) were admitted to Baragwanath hospital, 313(31%) at Tshepong 
hospital and 231(22%) at Selby hospital. Out of these patients, 1018 patients had known 
HIV status of whom 875 (86%) were HIV positive while 143 (14%) were HIV negative. All 
patients were above 18 years of age, although the majority were within the age group of 
30-44 (53%). 
 
Overall, the majority of patients were females (n=679, 67%). Among the 875 HIV positive 
patients, 603 (69%) were females while 269 (31%) were males. Of the 143 HIV negative 
patients, 73 (51%) were females and 70 (49%) were males. The analysis included those 
patients who had known HIV status. The flow diagram in Figure 1 shows the patients 
included in the analysis. 
 
Figure 3: Flow chart of patients enrolled in the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
1025 Patients with Suspected TB 
1018 Patients with known HIV status  
HIV positive patients (n=875, 86%) HIV negative patients (n=143, 14%) 
Males (n=269, 31%) Female (n= 603, 69%)  Male (n= 70, 49%) Female (n= 73, 51%)  
Admitted at Selby (n=231, 
22 %) 
Admitted at Tshepong 
(n=313, 31%) 
Admitted at 
Baragwanath (n=481, 
47%) 
Included in analysis: 
comparing patients 
with HIV positive 
versus HIV negative 
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3.2 Socio-demographic and clinical characteristics of patients 
 
All participants were within the age group of 18 to 83 years with an overall median age of 
36 years (IQR: 30 – 44 years). A comparison of patients by HIV status indicated that the 
HIV positive were significantly younger (36 vs. 42 years; p<0.0001) and had a higher 
proportion of females (69% vs. 51%; p<0.0001) compared to the HIV negative. 
Furthermore, more HIV positive patients were unemployed (61% vs. 44%; p<0.0001), and 
had sought treatment elsewhere (53% vs. 41%; p=0.009) relative to the HIV negative. 
 
Overall, there was almost an equal proportion of patients in different classes of socio-
economic status with 336(33%) being in the upper middle class, 317(32%) in the lower 
middle class and 347(35%) in the poor class. There were no significant differences in the 
proportion of patients among different socio-economic status categories in the HIV group 
compared with the HIV negative group (p=0.8). Furthermore, there were no significant 
differences as regards to body mass index and the number of people in each house for 
HIV positive patients compared to HIV negative patients (Table 1). 
 
Table 1: Characteristics of patients stratified by HIV status 
 
Characteristics  
Overall HIV Positive  HIV Negative 
P-Values 
(N=1018) (n=875) (n=143) 
Median (Q3-Q1) or 
n (%) 
Median (Q3-Q1) or 
n (%) 
Median (Q3-Q1) or 
n (%) 
Age groups (years)   
18-29 (%) 225 (22) 194 (22) 31 (22) <0.0001 
30-44 (%) 546 (54) 494 (57) 52 (36)   
> 45 (%) 244 (24) 184 (21) 60 (42)   
Median age(Q3-Q1)  36(30-44) 36(30-43) 42(31-51) < 0.0001 
Sex   
Male (%) 339 (33)  269 (31)  70 (49)  <0.0001 
Female (%) 676 (67) 603 (69) 73 (51)   
Socio-economic status   
Upper middle (%) 336 (33) 292 (34) 44 (31) 0.83 
Lower middle (%) 317 (32) 272 (32) 45 (32)   
Poor (%) 347 (35) 296 (34) 51(37)   
Type of house    
Brick House (%) 692 (68)  592 (68)  100 (70)  0.66 
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Other (%) 321 (32)  278 (32)  43 (30)    
No. of rooms in the house  
Median (Q3-Q1) 2 (2-2) 2 (2-3)  2 (1-2)  0.08 
No. of People in the house  
Median (Q3-Q1) 4 (3-6) 4 (3-6)  4(3-5)  0.13 
Crowding Index    
Median (Q3-Q1) 2 (1.5-3)  2 (1.5-3)  2 (1.5-3)  0.93 
Employment status   
Employed (%) 418 (41) 338 (39) 80 (56) <0.0001 
Unemployed (%)  597 (59) 534 (61)   63 (44)   
Ever smoked    
Yes (%) 246 (24)  193 (22)  53 (37)  <0.0001 
No (%) 770 (76)   680 (78) 90 (63)    
Ever used alcohol   
Yes (%) 291 (29)  238 (27)  53 (37)  0.02 
No (%) 723 (71)  633 (73)  90 (63)    
Hospital          
Baragwanath (%) 476 (47) 398 (46) 78 (55) <0.0001 
Klerksdorp (%) 311 (30) 290 (33) 21 (14)   
Selby (%) 231 (23) 187 (21) 44 (31)   
Admission time   
Weekend (%) 98 (10)  91 (10) 7 (5) 0.04 
Weekday (%) 917 (90)  781 (90) 136 (95)   
Sought treatment elsewhere  
Yes (%) 522 (51) 410 (47) 84 (59) 0.009 
No (%) 494 (49) 463 (53) 59 (41)   
Body Mass Index (kg/m
2
 ) 
Underweight (%) 293 (32)  255 (33) 38 (29) 0.09 
Normal (%) 483 (53)  417 (54) 66 (50)   
Overweight/Obese (%) 136 (15)  108 (14) 28 (21)   
Median BMI (Q3-Q1) 20(17.9 - 22.9) 20(17.9-22.8) 20.7(18.1-23.9) 0.05 
 
3.3 Distribution of Patient, Health system and Total delay in Days 
 
Overall patients across all age groups experienced higher patient delay compared to 
System delay as such patient delay contributed a larger proportion to the total delay. The 
distribution of all types of delay stratified by HIV status across different age groups is 
shown in Figure 2. 
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Figure 4: Median delay by HIV status across age groups 
 
 
 
3.3.1 Patient delay 
 
Longer patient delays were experienced among patients who were HIV positive compared 
to HIV negative patients (28 days (IQR, 21-56) vs. 21 days (IQR,14-42) days; p<0.0001). In 
particular, longer patient delays were experienced by HIV positive patients within the age 
groups of 18-29 and 30-44 years than their HIV negative counterparts. Significantly longer 
patients delays were further observed among HIV positive patients in the upper middle 
class compared to HIV negative patients of the same class (28 (IQR: 21-56) vs. 21 (IQR: 14-
28) days; p<0.0001). HIV positive patients who neither smoked nor used alcohol had 
significantly longer delays than HIV negative patients with the same characteristics (28 
(IQR: 21-56) vs. 21 (IQR: 14-42) days; p=0.0001) and (28 (IQR: 21-56) vs. 21 (IQR: 14-35) 
days; p=0.0002) respectively). Furthermore, HIV positive patients who were not taking 
cotrimoxazole or had sought treatment elsewhere had significant longer patient delays 
than HIV negative patients with similar characteristics. Table 2 shows the distribution of 
patient delays in days stratified by HIV status. 
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Table 2: Distribution of Patient delay in days by HIV Status 
 
Characteristic HIV Positive  HIV Negative P-Values 
n Median (Q3-Q1)  n Median (Q3-Q1)  
Overall  870 28(21-56) 143 21(14-42) 0.0001 
Age (years)           
18-29 194 28 (21-56) 31 21 (14-28) 0.01 
30-44 492 28 (21-56) 52 21 (14-28) 0.0005 
>45 183 28 (21-56) 60 28 (14-56) 0.17 
Sex           
Male 294 28 (21-56) 70 28 (14-49) 0.04 
Female  601 28 (21-56) 73 21 (14-42) 0.0004 
Socio-economic status           
Poor 294 28 (21-56) 51 21 (14-35) 0.1 
Lower middle 271 28 (21-49) 45 28 (14-42) 0.5 
Upper middle 292 28 (21-56) 44 21 (14-28) <0.0001 
Employment Status           
Unemployed 532 28 (21-56) 63 28 (14-56) 0.04 
Employed 337 28 (14-35) 80 21 (14-28) 0.01 
Ever smoked            
Yes 193 28 (21-56) 53 21 (14-42) 0.3 
No 677 28 (21-56) 90 21 (14-42) 0.0001 
Ever used alcohol           
Yes 237 28 (21-56) 53 28 (14-49) 0.08 
No 631 28 (21-56) 90 21 (14-35) 0.0002 
Body Mass Index (kg/m
2
 )          
Underweight 255 28 (21-56) 38 28 (21-56) 0.21 
Normal 416 28 (21-56) 66 21 (14-42) 0.04 
Overweight/obese  107 28 (14-56) 28 14 (14-28) 0.01 
Currently on cotrimoxazole         
Yes 113 28 (21-56) 1 56 (56-56) 0.57 
No 735 28 (21-56) 137 21 (14-42) 0.0006 
Sought treatment elsewhere          
Yes 454 28 (21-56) 59 21 (14-28) <0.0001 
No 401 28 (14-42) 81 21 (14-42) 0.3 
Hospital            
Baragwanath 398 28 (21-56) 78 21 (14-42) 0.01 
Klerksdorp  285 35 (28 - 56) 21 28 (14-56) 0.04 
Selby 187 28 (21 - 42) 44 21 (14-39) 0.5 
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3.3.2 Health system delay 
 
The median system delay days for HIV positive was 2 days (IQR: 1-10) and that of HIV 
negative patients was 2 days (IQR: 1 - 6). There was no significant difference in median 
days of system delay for HIV positive compared to HIV negative patients (P=0.41). The 
same scenario of non-significance difference between the median health system delays 
for HIV positive patients compared to HIV negative patients was observed for all other 
patient’s characteristics. Table 3 shows the distribution of health system delay in days by 
HIV status. 
 
Table 3: Distribution of Health system delay in days by HIV Status 
 
Characteristic HIV Positive  HIV Negative P Value 
n Median (Q3-Q1)  n Median (Q3-Q1)  
Overall  480 2(1-10)  55 2 (1 - 6) 0.41 
Age (years)           
18-29 110 2 (1-20) 15 1 (0-6) 0.3 
30-44 267 2 (1-10) 15 2 (1-4) 0.3 
>45 103 3 (0-9) 25 4 (1-7) 0.7 
Sex           
Male 145 3 (1-9) 29 2 (1-6) 0.6 
Female  335 2 (1-10) 26 1.5 (1-7) 0.4 
Socio-economic status           
Poor 139 3 (1-10) 19 1 (0-6) 0.1 
Lower middle 150 2 (1-10) 20 2 (1-4.5) 0.7 
Upper middle 185 3 (1-11) 16 5 (1-8.5) 0.3 
Employment Status           
Unemployed 306 2 (0-9) 27 1 (0-3) 0.1 
Employed 174 3 (1-12) 28 4 (2-7) 0.7 
Ever smoked            
Yes 96 2 (1-6) 19 2 (1-4) 0.8 
No 384 3 (1-11.5) 36 3 (1-6.5) 0.5 
Ever used alcohol           
Yes 131 3 (1-8) 22 2 (1-6) 0.96 
No 348 2 (1-11.5) 33 2 (1-6) 0.3 
Body Mass Index (kg/m
2
 )          
Underweight 159 2 (1-11) 20 2.5 (1-7) 0.8 
Normal 213 3 (1-10) 24 2 (0-6) 0.3 
Overweight/obese  56 4.5 (1-13) 8 2.5 (1-7) 0.5 
Currently on cotrimoxazole          
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Yes 67 6 (1-22) 1 1 (1-1) 0.4 
No 397 2 (1-9) 51 2 (1-6) 0.7 
Sought treatment elsewhere          
Yes 287 5 (1-20) 30 4.5 (1-10) 0.5 
No 193 1 (0-4) 25 1 (0-3) 0.7 
Hospital            
Baragwanath 215 3 (1-14) 30 2.5 (1-7) 0.6 
Klerksdorp  203 1 (0-7) 16 1 (1-4.5) 0.8 
Selby 62 4 (0- 9) 9 3 (0- 4) 0.2 
 
3.3.3 Total delay 
 
Overall, HIV positive patients had significantly longer total median delay relative to the 
HIV negative (39, IQR: 28-74 vs. 32, IQR: 21 – 56; p =0.02). Longer total median delays 
were significantly higher among poor HIV positive patients compared with the poor HIV 
negative (31.5, IQR: 22-82 vs. 27, IQR: 18-35; p< 0.03). Longer total median delays were 
also experienced by HIV positive patients who never smoked compared to HIV negative 
patients of the same category (41.5, IQR: 28-75 vs. 34.5, IQR: 21-51; p< 0.02). 
Furthermore, HIV positive patients who had sought treatment elsewhere had longer total 
median delays than the HIV negative patients of the same characteristics (56, IQR: 30-89 
vs. 33.5, IQR: 27-57; p< 0.003). There was no significant difference in the median total 
delays in days with regard to age, gender, employment status, alcohol use, body mass 
index, type of hospital and use of cotrimoxazole between the HIV positive and HIV 
negative patients as shown in Table 4: 
 
Table 4: Distribution of Total delay in days 
 
Characteristic HIV Positive  HIV Negative P Value 
n Median (Q3-Q1 n Median (Q3-Q1 
Overall 478 39(28-74) 55 32(21-56) 0.02 
Age (years)           
18-29 110 40.5 (28-87) 15 29 (16-55) 0.07 
30-44 265 37 (28-69) 15 28 (21-45) 0.06 
>45 103 43 (28-72) 25 35 (28-57) 0.36 
Sex           
Male 145 34 (27-84) 29 32 (23-57) 0.24 
Female  333 42 (28-72) 26 34.5 (21-45) 0.05 
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Socio-economic status           
Poor 138 31.5 (22-82) 19 27 (18-35) 0.03 
Lower middle 149 32 (28-59) 20 43.5 (29-57) 0.69 
Upper middle 185 44 (29-78) 16 33.5 (22-59.5) 0.1 
Employment Status           
Unemployed 304 45.5 (29-84.5) 27 42 (28-57) 0.19 
Employed 174 31 (23-57) 28 27.5 (19.5-40) 0.13 
Ever smoked            
Yes 96 33 (22.5-69) 19 31 (23-57) 0.56 
No 382 41.5 (28-75) 36 34.5 (21-51) 0.02 
Ever used alcohol           
Yes 130 43 (27-85) 22 30 (27-57) 0.16 
No 347 39 (28-70) 33 34 (21-47) 0.06 
Body Mass Index (kg/m
2
 )          
Underweight 159 42 (28-70) 20 34.5 (28-56) 0.44 
Normal 212 37.5 (28-78) 24 31.5 (22-60) 0.18 
Overweight/obese  55 39 (21-77) 8 28.5 (18.5-38.5) 0.15 
Currently on cotrimoxazole          
Yes 67 60 (31-99) 1 57 (57-57) 0.89 
No 395 35 (28-62) 51 32 (23-55) 0.08 
Sought treatment elsewhere          
Yes 285 56 (30-89) 30 33.5 (27-57) 0.003 
No 193 29 (21-52) 25 32 (17-43) 0.88 
Hospital            
Baragwanath 215 32 (24-73) 30 28.5 (21-55) 0.05 
Klerksdorp  201 56 (29-85) 16 37.5 (21-57) 0.07 
Selby 62 29 (24-48) 9 35 (32-45) 0.08 
 
3.4 Predictors of Prolonged Patient delay 
 
Univariable and multivariable analyses were done to determine the predictors of 
prolonged patient delay in the diagnosis and treatment of suspected TB cases. 
 
3.4.1 Univariable analysis 
 
To understand the relationship between each predictor variable and the outcome, 
prolonged patients delay, the odds ratios of each predictor variable stratified by HIV 
status were calculated. For patients who were HIV positive, significant results were 
obtained for socio-economic status, crowding index, employment status, body mass 
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index, type of hospital, taking cotrimoxazole and sought treatment elsewhere. However, 
for HIV negative patients, only employment status predicted the prolonged patient delay 
outcome. 
 
HIV positive patients in the upper middle class had higher odds of experiencing prolonged 
patients delay (OR 1.6, 95% C.I: 1.1-2.2) compared to the HIV positive patients who 
belonged to the poor class of socio-economic status. Crowding index was protective since 
a unit increase in crowding index was found to be associated with reduced odds of 
prolonged patient delay protective among HIV positive patients (OR 0.8, 95% C.I: 0.7- 0.9). 
The odds of prolonged patient delay were high among the unemployed patients in both 
HIV positive (OR 2.2, 95%CI: 1.7- 3.01) and HIV negative (OR 2.6, 95%CI: 1.2-5.5) groups. 
 
HIV positive patients were also more likely to experience prolonged patient delay if they 
were taking cotrimoxazole (OR1.8, 95% CI: 1.2- 2.7), had sought prior treatment 
elsewhere (OR 2.2, 95% CI: 1.7- 2.9), were admitted to Tshepong (OR 2.3, 95% CI: 1.7- 3.1) 
and were underweight (OR 1.7, 95% CI: 1.2 - 2.3). 
 
3.4.2 Multivariable analysis 
 
In multivariate analysis, crowding index, employment status, body mass index, taking 
cotrimoxazole and sought treatment elsewhere significantly predicted the prolonged 
patient delay for HIV positive patients while employment status predicted the outcome 
for HIV negative patients. Among the HIV positive patients, there were no changes in the 
Odd of delay for crowding index in both the Univariate and multivariate model. However, 
minor decreases in the odds ratio were observed for body mass index, taking 
cotrimoxazole sought treatment elsewhere. The Adjusted Odds Ratio (AOR) of patient 
delay among the unemployed were slightly higher (AOR 2.6, 95% CI: 1.8- 3.8) in the 
multivariate model of HIV positive patients while the odds of delay remained the same in 
the multivariate model of HIV negative patients. Table 5 shows the univariate and 
multivariate analyses for prolonged patient delay stratified by HIV status. 
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Table 5: Predictors of Prolonged Patient Delays ( > 28 Days) in Tuberculosis Diagnosis and Treatment 
 
Characteristics  
HIV Positive HIV Negative 
Univariable P-Value Multivariable P-Value Univariable P-Value Multivariable P-Value 
OR (95% CI)   AOR (95% CI)   OR (95% CI)   AOR (95% CI)   
Age_Cat (years)                 
18-29  1.0   _ _ 1.0       
30 - 44 0.9 (0.6-1.2) 0.4 _ _ 0.9 (0.3- 2.7) 0.9 _ _ 
>45  1.1 (0.7-1.6) 0.7 _ _ 2.1 (0.8- 5.7) 0.1 _ _ 
Gender                 
Male 0.99 (0.7- 1.6) 0.9 _ _ 1.3 (0.6- 2.7) 0.5 _ _ 
Female 1.0   _ _ 1.0   _ _ 
Crowding Index  0.8 (0.7- 0.9) 0.002 0.8 (0.7- 0.9) 0.01 0.9 (0.7- 1.3) 0.6 _ _ 
Employment status                 
Employed  1.0 
 
1.0   1.0   1.0   
Unemployed  2.2 (1.7- 3.0) <0.0001  2.6 (1.8- 3.8) <0.0001 2.6 (1.2-5.5) 0.001 2.6 (1.2- 5.8) 0.02 
Ever smoked                  
Yes  0.9 (0.6- 1.2) 0.4 _ _ 1.1 (0.5- 2.4) 0.8 _ _ 
No 1.0   _ _ 1.0   _ _ 
Alcohol use                 
Yes  1.1 (0.8- 1.5) 0.4 _ _ 1.5 (0.7- 3.1) 0.3 _ _ 
No 1.0   _ _     _ _ 
BMI (kg/m
2
 )                 
Normal  1.0   1.0   1.0   1.0   
Underweight 1.7 (1.2 - 2.3) 0.001 1.6 (1.1- 2.3) 0.01 1.9 (0.8 - 4.5) 0.12 1.7 (0.7- 4.1) 0.2 
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Overweight/Obese  1.02 (0.7- 1.6) 0.9 0.8 (0.5 - 1.3) 0.3 0.4 (0.1-1.5) 0.18 0.4 (0.1- 1.2) 0.1 
Hospital                  
Baragwanath 1.0   1.0   1.0   _ _ 
Klerksdorp  2.3 (1.7- 3.1) <0.0001 1.4 (0.9- 2.1) 0.09 1.7 (0.6- 4.6) 0.3 _ _ 
Selby 0.9 (0.6- 1.3) 0.6 1.1 (0.7- 1.8) 0.6 1.02 (0.4- 2.3) 0.97 _ _ 
Sought treatment elsewhere               
Yes  2.2 (1.7- 2.9) <0.0001 1.8 (1.2- 2.5) 0.002 0.7 (0.3- 1.4) 0.3 _ _ 
No  1.0   1.0   1.0   _ _ 
Cotrimoxazole                 
Yes  1.8 (1.2- 2.7) 0.003 1.7 (1.04- 2.6) 0.03 _ _ _ _ 
No 1.0   1.0   _ _ _ _ 
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3.5 Predictors of Prolonged Health system delay 
 
Univariable and multivariable analyses stratified by HIV status were done to determine 
the predictors of prolonged health system delay in the diagnosis and treatment of 
suspected TB cases. 
 
3.5.1 Univariable analysis 
 
In the univariable analysis, we found that crowding index and sought treatment 
elsewhere were significant predictors of prolonged health system delay for the HIV 
positive patients while there was no significant predictor among the HIV negative 
patients. 
 
Crowding index (OR 0.7, 95% CI: 0.6- 0.9) was found to be protective whereas HIV positive 
patients who had sought treatment elsewhere (OR 4.7, 95% CI: 2.9- 7.6) had higher odds 
of experiencing prolonged health system delay than those who never sought treatment. 
 
3.5.2 Multivariable analysis 
 
Crowding index and sought treatment elsewhere predicted prolonged health system 
delay among HIV positive patients in the multivariate analysis. Crowding index was 
protective (AOR 0.8, 95% CI: 0.7- 0.97) while patients who sought prior treatment had 
higher odds of prolonged health system delay relative to those who never sought 
treatment (AOR 4.5, 95% CI: 2.7- 7.3). Table 6 shows the univariate and multivariate 
analyses for prolonged health system delay stratified by HIV status.
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Table 6: Predictors of Prolonged System Delay (> 7 Days) in Tuberculosis Diagnosis and Treatment 
Characteristics  
HIV Positive HIV Negative 
Univariable P-Value Multivariable P-Value Univariable P-Value Multivariable P-Value 
OR (95% CI)   AOR (95% CI)   OR (95% CI)   AOR (95% CI)   
Age_Cat (years)                 
18-29  1.0   _ _ 1.0   _ _ 
30 - 44 0.9(0.5- 1.4) 0.6 _ _ 1.0 _ _ _ 
>45  0.9(0.5- 1.7) 0.8 _ _ 1.3(0.3- 6.02) 0.8 _ _ 
Gender     _ _     _ _ 
Male 0.99(0.6- 1.5) 0.97 _ _ 1.2(0.3- 4.8) 0.9 _ _ 
Female 1.0   _ _ 1.0   _ _ 
Crowding Index  0.7 (0.6- 0.9) 0.002 0.8(0.7- 0.97) 0.03 1.3(0.7- 2.3) 0.5 _ _ 
Employment status             _ _ 
Employed  1.0   _   1.0   _ _ 
Unemployed  0.9 (0.6- 1.3) 0.5     0.5(0.1- 2.1) 0.3 _ _ 
Ever smoked      _       _ _ 
Yes  0.7 (0.4- 1.1) 0.1     1.2(0.3- 5.3) 0.8 _ _ 
No 1.0   _   1.0   _ _ 
Alcohol use     _       _ _ 
Yes  0.8 (0.5- 1.2) 0.3     1.7(0.4- 7.1) 0.5 _ _ 
No 1.0   _   1.0   _ _ 
BMI (kg/m
2
 )             _ _ 
Normal  1.0   _   1.0   _ _ 
Underweight 1.01 (0.6- 1.6) 0.95     1.7 (0.4 - 7.3) 0.5 _ _ 
Overweight/Obese  1.4 (0.7- 2.6) 0.3     1.0 _ _ _ 
Hospital      _       _ _ 
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Baragwanath 1.0   _   1.0   _ _ 
Klerksdorp  0.7 (0.42- 0.99) 0.05 _   0.5(0.1- 2.6) 0.4 _ _ 
Selby 1.02(0.56- 1.8) 0.96 _   1 _ _ _ 
Sought treatment elsewhere           _ _ 
Yes  4.7(2.9- 7.6) <0.0001 4.5(2.7- 7.3) <0.0001 - _ _ _ 
No  1.0   1   -   _ _ 
Cotrimoxazole             _ _ 
Yes  1.7(0.99- 2.9) 0.05     - _ _ _ 
No 1.0   _   - _ _ _ 
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3.6 Predictors of Prolonged Total delay 
Univariable and multivariable analyses were done to determine the predictors of 
prolonged total delay in the diagnosis and treatment of suspected TB cases. 
 
3.6.1 Univariable analysis 
During the univariable analysis for patients who were HIV positive, significant results were 
obtained for crowding index, employment status, type of hospital, taking cotrimoxazole 
and sought treatment elsewhere. However, for HIV negative patients, only employment 
status predicted the prolonged total delay outcome. 
 
Higher odds of prolonged delay were experienced among the unemployed HIV positive 
patients (OR 1.95, 95% CI: 1.3-2.9) compared to the employed patients. The situation was 
the same among the unemployed HIV negative patients. However, the odds were much 
higher (OR 4.2, 95% CI: 0.9-19.5) for the group. 
 
The odds of prolonged delay were lower with a unit increase in crowding index (OR 0.8, 
95% CI: 0.7 -0.9) among the HIV positive group. HIV positive patients were also more 
likely to experience prolonged total delay if they were taking cotrimoxazole (OR 2.4, 95% 
CI: 1.4 -4.1), had sought prior treatment elsewhere (OR 4.5, 95% CI: 3.1-6.8) and were 
admitted to Tshepong (OR 1.9, 95% CI: 1.3-2.9). 
 
3.6.2 Multivariable analysis 
In multivariable analysis, employment status, taking cotrimoxazole and sought treatment 
elsewhere significantly predicted the prolonged total delay for HIV positive patients while 
there was no significant predictor for HIV negative patients. The odds of delay were 
higher for those who were taking cotrimoxazole (AOR 2.6, 95% CI: 1.4-4.8) and the 
unemployed (AOR 2.4, 95% CI: 1.5-3.8) HIV positive patients. Higher odds of delay were 
experienced among the HIV positive patients who sought treatment elsewhere (AOR 4.3, 
95% CI: 2.7-6.6), although the odds were slightly lower in multivariate compared to 
univariate models. Table 7 below shows the univariate and multivariate analyses for 
prolonged total delay stratified by HIV status. 
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Table 7: Predictors of Prolonged Total Delay (> 35 Days) in Tuberculosis Diagnosis and Treatment 
Characteristics  HIV Positive HIV Negative 
Univariable P-Value Multivariable P-Value Univariable P-Value Multivariable P-Value 
OR (95% CI)   AOR (95% CI)   OR (95% CI)   AOR (95% CI)   
Age_Cat (years)                 
18-29  1.0   _   1.0   _   
30 - 44 1.0(0.6-1.6) 0.995 _   1.0 (0.2 - 4.6) 1.0 _   
>45 1.4(0.8-2.3) 0.28 _   1.9 (0.5-6.9) 0.4 _   
Gender                 
Male 0.8(0.6-1.3) 0.4 _   0.8 (0.3 -2.5) 0.7 _   
Female 1.0   _   1.0   _   
Crowding Index  0.8 (0.7 -0.9) 0.02  0.9 (0.7 -1.03) 0.1 1.1 (0.6 -1.8) 0.8 _   
Employment status                 
Employed  1.0   1.0   1.0   1.0   
Unemployed  1.95 (1.3-2.9) 0.001 2.4 (1.5-3.8) 0.001 3.8 (1.2 -11.8) 0.02 4.2 (0.9-19.5) 0.07 
Ever smoked                  
Yes  0.8 (0.5-1.2) 0.3 _   0.8 (0.3 -2.6) 0.7 _   
No 1.0   _   1.0   _   
Alcohol use             
Yes  1.1(0.7-1.6) 0.7 _   1.1 (0.4 -3.2) 0.9 _   
No 1.0   _   1.0   _   
BMI (kg/m
2
 )                 
Normal  1.0       1.0   _   
Underweight 1.1 (0.7 -1.7) 0.6 _   1.15 (0.35 -3.8) 0.8 _   
Overweight/Obese  1.2(0.6 -2.1) 0.6 _   0.5 (0.1 - 2.5) 0.4 _   
Hospital                  
Baragwanath 1.0   1.0   1.0   1.0   
37 
 
 
 
 
 
 
 
 
 
Klerksdorp  1.9 (1.3-2.9) 0.001 1.1 (0.7-1.9) 0.6 2 (0.6-6.9) 0.3 0.7 (0.1-3.7) 0.6 
Selby 0.6 (0.3-1.02) 0.1 0.8 (0.4 -1.5) 0.5 1.6 (0.4-7.3) 0.5 2.4 (0.3-17.5) 0.4 
Sought treatment elsewhere                
Yes  4.5 (3.1-6.8) <0.0001 4.3 (2.7-6.6) <0.0001 1.4 (0.5 -4.04) 0.6 _   
No  1.0   1.0   1.0   _   
Cotrimoxazole                 
Yes  2.4 (1.4 -4.1) 0.003 2.6 (1.4-4.8) 0.003 -   _   
No 1.0   1.0   -   _   
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CHAPTER FOUR: DISCUSSION 
 
4.1 Distribution of delay 
 
There is limited research from South Africa that examines delays in TB diagnosis and 
treatment by HIV status despite the high HIV and TB burden. Our study found a higher 
patient and total delays in HIV positive patients compared to the HIV negative. To the 
contrary, a cross-sectional study conducted in Thailand found shorter patient and total 
delays in HIV positive patients compared to the HIV negative (36). According to the Thailand 
study, these shorter delays in HIV positive patients were attributed to high health insurance 
coverage, easy access and acquaintance with the services provided by the healthcare 
facilities (36). In our set-up, it may be that the longer delays among the HIV positive would 
have resulted from several factors including a poor understanding of TB symptoms, seeking 
care elsewhere before TB diagnosis and affordability as suggested by the high 
unemployment rates. Additionally, health care workers in Thailand may have had a higher 
index of TB suspicion for HIV positive patients resulting in earlier diagnosis and treatment of 
TB cases which led to shorter delays (48). However, our distribution of delays concurs with 
the results of a study undertaken in Hohoe municipality in Ghana (23) and a descriptive 
cross-sectional study conducted in Zimbabwe (17). The similarity of the distribution of our 
delays to the results found in these studies could be attributed to the premise that both 
settings share similar demographic characteristics and experience a high burden of TB and 
HIV similar to our study setting. 
  
Studies have demonstrated that there is no association between prolonged patient delay 
and HIV status (17, 23) while other authors have documented that HIV positive patients are 
more likely to have reduced odds of prolonged patient delay than the HIV negative 
counterparts (36). However, our comparison of the delays among HIV positive and HIV 
negative patients revealed that higher odds of prolonged delays were experienced among 
patients who were HIV positive. Furthermore, the findings revealed that HIV status acts as 
an effect modifier when prolonged patient delay is investigated against other exposures like 
whether the patient sought treatment prior to TB diagnosis. Similar results were found from 
a study conducted in an HIV epidemic area, whose aim was to investigate the association 
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between HIV awareness and patient-related delay in diagnosis and treatment of TB (46). 
According to the study, confusion between the signs and symptoms of TB and HIV among 
HIV positive patients results in delays in seeking treatment for TB (46). Longer patient delays 
among HIV positive patients could have also been a result of stigma and discrimination. 
Studies have revealed that enacted and internalised stigma was correlated with delays in 
seeking care after testing HIV-positive (14, 37). 
 
The level to which health workers suspect TB in a patient, also known as the Index of TB 
suspicion by health care workers, is among the main factors that affect health system delay 
(16). In developing countries where TB prevalence is very low, there is a low index of TB 
suspicion by health care workers which results in longer health system delays (47). On the 
contrary, the index of TB suspicion among health care workers in TB endemic settings is high 
and this result in shorter health system delays (48). Our results showed no significant 
differences in the median health system delay by HIV status. This could imply that in our 
setting, the health system manages TB cases in the same way regardless of HIV status. Our 
results concur with results found in studies conducted in Ghana and India (23, 26). However, 
a study carried out in Northwest Ethiopia in the year 2014 found different results from our 
study in which HIV negative patients had longer health system delay than HIV positive 
patients (8). Possible explanations in such settings could be that the HIV positive TB patients 
might have presented with severe symptoms indicative of TB due to co-infection with HIV 
and also there might have been high levels of awareness among health workers regarding 
HIV and TB co-infection which made it easier to suspect TB among HIV cases (8). The data 
for this study was collected between 2006 to 2009.During such period, healthcare worker’s 
awareness regarding HIV and TB co-infection was not as high as during the time the 
Northwest Ethiopian study was conducted (8) when there was rapid awareness regarding 
co-infections of HIV and TB. This could be the key reason why differences in the results are 
observed from our study and recent studies. 
 
4.2 Determinants of Delay 
 
The odds of prolonged patient delay were twice as much among the unemployed patients 
compared to the employed in both HIV positive and HIV negative patients. Similarly, higher 
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odds of prolonged total delay were experienced among the unemployed patients. A 
systematic review conducted by Cai and colleagues revealed similar results  with our 
findings (49). Furthermore, a cohort study conducted by Dos Santos in Brazil’s semi-urban 
area almost the same setting as our study area found same results with our study (39). 
According to Dos Santos, the majority of employed patients had attained some education 
and had access to TB awareness programs (39). This made it easy for them to quickly notice 
the signs and symptoms of TB and understand the benefits of early diagnosis and treatment. 
In our study setting, however, employment is highly linked to SES. Therefore, 
unemployment which may ultimately lead to low income may reduce the likelihood of 
potential TB patients to seek care after experiencing signs and symptoms of TB compared to 
the employed who may have adequate financial resources to seek medical attention (50). 
 
HIV positive patients who were underweight had higher odds of prolonged patient delay. 
However, we did not experience any significant difference in the odds of prolonged total 
delay and prolonged system delay with regard to BMI. To the contrary, different results 
emanated from a study conducted in Brazil where patients with weight loss which indicates 
underweight BMI reduced odds of prolonged patient and total delay (39). Such difference 
could occur because BMI has been associated with SES in many resources limited settings 
where normal or overweight individuals are considered of high SES unlike the underweight 
(17). Being underweight could, therefore, have a similar effect as being of low SES where 
resources to seek medical care after experiencing signs of TB could be a challenge (18, 19). 
 
Our study revealed that HIV positive patients were more likely to experience prolonged 
patient, health system and total delays if they had sought prior treatment elsewhere. 
Studies conducted in Ghana, Angola and Thailand reported the same and the reason being 
that patients who visit different multiple health care providers make it difficult for the 
providers to reach a prompt TB diagnosis (18, 19, 23). Similar explanations could apply in 
our study setting. In addition to such explanation, patients in our study would have been 
assured of getting better upon seeking treatment from other sources. The period they 
anticipate to get better upon receiving prior treatment would therefore lead to delays. 
However, other authors have attributed delays associated with seeking prior treatment to 
nonspecific test results and atypical clinical features (51, 52). 
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We found that higher odds of prolonged patient and total delay were experienced by HIV 
positive patients who were taking cotrimoxazole. HIV infection leads to opportunist 
infections most of which are bacterial in nature(1). In an attempt to lessen the suffering 
from the bacterial opportunist infections most of the patients seek antibiotics of which the 
common one is cotrimoxazole. Taking cotrimoxazole which potentially has some anti-TB 
infection remedy could have resulted in lessening the symptoms for a short period, and the 
patients could have thought that they would recover which ultimately led to the prolonged 
delay. Authors have reported similar findings in both developed and developing countries 
(8, 21, 24, 25). 
 
Crowding index was protective of both prolonged patient and health system delay among 
HIV positive patients. A study conducted in the Bale zone of south-east 
Ethiopia found similar results (15). Since overcrowding is associated with ease of TB 
transmission (48, 53), it may imply that healthcare workers treated suspected TB patients 
who came from overcrowded houses with urgency to prevent further transmission and this 
resulted in lower odds of prolonged health system delay. Likewise, the fear of spreading TB 
to other household members and support from other family members could have been the 
reason why crowding index was found to be protective of prolonged patient delay. 
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CHAPTER FIVE: CONCLUSION AND RECOMMENDATIONS 
 
5.1 Conclusion and recommendations 
 
This study has compared the determinants of delay in the diagnosis and treatment of 
suspected TB among HIV positive and HIV negative patients in a setting where there is a 
high burden of TB and HIV. This is a critical comparison since it relates to individual patient 
outcomes and TB transmission in resource-limited and dynamic societies. Higher patient 
delays compared to health system delays suggests that health promotion interventions 
targeting patient delays could be more effective at improving individual patient outcomes 
and control the spread and the negative impacts associated with TB infection. There is, 
therefore, a need for more community awareness interventions aimed at sensitising the 
communities about the signs and symptoms suggestive of TB disease and the importance of 
seeking medical care in a timely manner. Targeted public health interventions focusing on 
HIV positive people should also be employed since there is a high risk of TB and HIV co-
infection. 
 
Since HIV positive patients had higher odds of experiencing prolonged health system delay 
than the HIV negative patients, deliberate efforts should be made to strengthen TB 
diagnostics services among HIV positive patients. Regular refresher training courses that 
address the importance of high index of suspicion for TB, particularly among HIV positive 
patients, should be provided to healthcare workers. Referral systems should be 
strengthened such that health facilities that do not offer TB diagnostic services should be 
able to promptly refer the suspected patients to a hospital that provide the service on time. 
Alternatively, the government may empower and actively involve the private General 
Practitioners (GPs) in the diagnosis of TB since the majority of patients visit a GP during their 
illness. 
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5.2 Strengths and limitations of the study 
 
The strengths and limitations of the study are discussed based on the classification of 
exposures and outcomes; applicability of the results to other settings; confounding and 
effect modification and appropriateness of analysis methods. 
 
A significant strength in our observed variables is that the data are consistently updated, 
corrected, and checked for inconsistencies. However, there are some biases related to the 
classification of exposures and outcomes. Firstly, information on occurrence and duration of 
symptoms suggestive of TB was prone to recall bias because it was self-reported. This could 
have affected the calculation of patient delay since the participants may not correctly 
remember the first day the first symptoms of TB occurred. Secondly, the use of differential 
diagnosis of TB as an inclusion criterion could have resulted in misclassification on study 
participants hence leading to selection bias. Furthermore, use of secondary data meant that 
we had no control of data quality during the data collection phase and other information on 
potential confounders was not collected. 
 
The data was collected from patients who were hospitalised in the three hospitals. Other 
potential patients who could have formed part of our study may have opted for other 
hospitals, and some may not even seek any medical care and this subjected our study to 
selection bias. Additionally, data may be outdated since it was collected from 2006 to 
2009.In recent years many developments in diagnosis and treatment of TB have been 
initiated and the results may therefore not applicable in such circumstances. Furthermore, 
since data was collected in a high TB and HIV incidence area, the findings may not be 
generalisable to other settings with a low burden of TB and HIV. 
 
Although we had a relatively smaller number of HIV negative patients compared to the HIV 
positive, we used logistic regression models which mitigated this discrepancy as it compares 
proportions as opposed to actual numbers. Furthermore, effect modification was 
investigated and dealt with through stratified analysis. Additionally, multiple logistic 
regression was conducted to control for confounding variables. 
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